We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Our Lifelong Immunity Relies on APRIL

News   Jun 03, 2020 | Original story from Tokyo Medical and Dental University

 
Our Lifelong Immunity Relies on APRIL

Credit: Department of Pediatrics, Perinatal and Maternal Medicine, TMDU

 
 
Advertisement
 

RELATED ARTICLES

Single Dose of Tocilizumab Linked to 45% Lower Risk of Dying Among COVID-19 Patients on Ventilators

News

Critically ill COVID-19 patients who received a single dose of intravenous tocilizumab were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment, compared with those who didn't receive the drug, according to new research conducted by University of Michigan scientists.

READ MORE

New Strategy To Stop the Spread of Childhood Bone Cancer

News

A set of key genes has been discovered that drive bone cancer spread to the lungs in patients. In mice with engineered human bone cancer cells that lack these key genes, the cancer could not spread to the lungs.

READ MORE

Lab-on-a-Chip Detects Blood Type Within Minutes

News

Scientists have developed a lab-on-a-chip device that can not only tell blood type within five minutes, but also allows medical staff to read the results through simple visual inspections.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE